Ankerstar Wealth’s Avanos Medical AVNS Stock Holding History

Ankerstar Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$572	Hold	23	–	–	﹤0.01%	614
2026 Q1	$322	Buy	23 +19	+475%	+$256	﹤0.01%	737
2025 Q4	$45	Buy	+4	New	+$46	﹤0.01%	1020

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Ankerstar Wealth's AVNS Position: Q2 2026 in Review

Ankerstar Wealth held its Avanos Medical (AVNS) position steady in Q2 2026 at 23 shares worth $572. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Ankerstar Wealth first reported a position in AVNS in Q4 2025 and has held it in 3 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Ankerstar Wealth held 23 shares of Avanos Medical worth $572 as of Q2 2026.
Ankerstar Wealth left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Ankerstar Wealth's portfolio in Q2 2026, its #614 holding.
Ankerstar Wealth first reported a position in Avanos Medical in Q4 2025 and has held it in 3 quarters since.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.